Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Anesthesiology Reports
Erschienen in: Current Anesthesiology Reports 4/2018

01.12.2018 | Cancer Anesthesia (B Riedel and V Gottumukkala, Section Editors)

Cancer Tsunami: Emerging Trends, Economic Burden, and Perioperative Implications

verfasst von: Patrick J. McCormick

Erschienen in: Current Anesthesiology Reports | Ausgabe 4/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This review discusses global trends in cancer mortality and survival, the socioeconomic drivers of those trends, and recent innovations in cancer surgery.

Recent Findings

Cancer is a leading cause of death worldwide. Cancer, previously a disease primarily of wealthy countries, is rapidly becoming a leading cause of death in low- and middle-income countries. Major economic forces driving global cancer trends include aging, frailty, and obesity. Alcohol consumption, poor diet, and lack of exercise also contribute to cancer types associated with modifiable causes. Surgery is responsible for 65% of cancer care globally, providing an opportunity for anesthesiologists to improve that care. Anesthesiologists can contribute to cancer remission through perioperative interventions that reduce risk of metastasis and speed return to intended oncologic therapy.

Summary

Cancer surgery comprises a large proportion of anesthetic caseload. Good outcomes come from high-volume cancer centers using a multidisciplinary approach.
Literatur
1.
Meara JG, Leather AJM, Hagander L, Alkire BC, Alonso N, Ameh EA, et al. Global surgery 2030: evidence and solutions for achieving health, welfare, and economic development. Lancet. 2015;386:569–624.CrossRefPubMed
2.
3.
• Naghavi M, Abajobir AA, Abbafati C, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet (London, England). 2017;390:1151–210 Provides annual estimates for more causes of death than the WHO GHE grouped by age, gender, location, and year.CrossRef
4.
5.
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC cancer base no. 11. 2013; http://​globocan.​iarc.​fr. Accessed 24 Aug 2018.
6.
Center MM, Jemal A, Lortet-Tieulent J, Ward E, Ferlay J, Brawley O, et al. International variation in prostate cancer incidence and mortality rates. Eur Urol. 2012;61:1079–92.CrossRefPubMed
7.
8.
•• Allemani C, Matsuda T, Di Carlo V, et al. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391:1023–75 Report of the third cycle of the CONCORD program to estimate worldwide cancer survival metrics. Survival is generally increasing in most countries, with increases of up to 5% for liver, pancreatic, and lung cancer.CrossRefPubMedPubMedCentral
9.
10.
11.
Cancer Registry of Norway. Cancer in Norway 2016 - cancer incidence, mortality, survival and prevalence in Norway. Oslo: Cancer Registry of Norway; 2017.
12.
Zeng H, Chen W, Zheng R, Zhang S, Ji JS, Zou X, et al. Changing cancer survival in China during 2003–15: a pooled analysis of 17 population-based cancer registries. Lancet Glob Health. 2018;6:e555–67.CrossRefPubMed
13.
Stewart BW, Wild CP, editors. World cancer report 2014. Lyon: WHO Press; 2014.
14.
15.
United Nations. World population prospects the 2017 revision key findings and advance tables. World Popul Prospect. 2017;2017:1–46.
16.
17.
Baijal P, Periyakoil V. Understanding frailty in cancer patients. Cancer J (United States). 2014;20:358–66.
18.
•• Shahrokni A, Kim SJ, Bosl GJ, Korc-Grodzicki B. How we care for an older patient with cancer. J Oncol Pract. 2017;13:95–102 Describes the importance of the geriatric assessment in the colorectal cancer population. Includes a list of interventions by the authors’ geriatric service at each stage of perioperative care.CrossRefPubMedPubMedCentral
19.
•• Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K, et al. Body fatness and cancer--viewpoint of the IARC working group. N Engl J Med. 2016;375:794–8 Authoritative review of evidence for the association of obesity with site-specific cancer. The review found that 13 different cancers had sufficient evidence to say that they are associated with obesity.CrossRefPubMedPubMedCentral
20.
21.
Steele CB, Thomas CC, Henley SJ, Massetti GM, Galuska DA, Agurs-Collins T, et al. Vital signs : trends in incidence of cancers associated with overweight and obesity — United States, 2005–2014. MMWR Morb Mortal Wkly Rep. 2017;66:1052–8.CrossRefPubMedPubMedCentral
22.
• Zheng Y, Manson JE, Yuan C, Liang MH, Grodstein F, Stampfer MJ, et al. Associations of weight gain from early to middle adulthood with major health outcomes later in life. JAMA - J Am Med Assoc. 2017;318:255Important analysis of two large cohort studies showing that weight gain during adulthood was associated with significantly increased risk of major chronic diseases, including cancer. Higher amounts of weight gain were associated with greater risks of major chronic diseases and a lower chance of healthy aging.CrossRef
23.
Ng M, Freeman MK, Fleming TD, Robinson M, Dwyer-Lindgren L, Thomson B, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA - J Am Med Assoc. 2014;311:183–92.CrossRef
24.
• GBD 2016 Alcohol Collaborators. Alcohol use and burden: a systematic analysis from the Global Burden of Disease Study 2016 for 195 countries and territories, 1990–2016. Lancet. 2018;6736:1–21 Controversial study calling for global reduction in alcohol consumption due to the number of annual global deaths that can be attributed to alcohol. Alcohol use was the leading risk factor in deaths among those aged 15–49. In the over 50-year-old population, cancers constituted a large proportion of alcohol-attributable deaths. The level of alcohol consumption that minimized harm was zero (95% CI 0.0–0.8) standard drinks per week.
25.
26.
Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, el Ghissassi F, et al. A review of human carcinogens–part B: biological agents. Lancet Oncol. 2009;10:321–2.CrossRefPubMed
27.
Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the human development index (2008-2030): a population-based study. Lancet Oncol. 2012;13:790–801.CrossRefPubMed
28.
• Pearson-Stuttard J, Zhou B, Kontis V, Bentham J, Gunter MJ, Ezzati M. Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment. Lancet Diabetes Endocrinol. 2018;6:e6–e15 Using GLOBOCAN and a review of articles associating high BMI and diabetes with site specific cancer, these researchers estimated the number of new cancer cases attributable to obesity and diabetes.CrossRefPubMedPubMedCentral
29.
Islami F, Goding Sauer A, Miller KD, Siegel RL, Fedewa SA, Jacobs EJ, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68:31–54.CrossRefPubMed
30.
Weiser TG, Haynes AB, Molina G, Lipsitz SR, Esquivel MM, Uribe-Leitz T, et al. Size and distribution of the global volume of surgery in 2012. Bull World Health Organ. 2016;94:201–209F.CrossRefPubMedPubMedCentral
31.
•• Sullivan R, Alatise OI, Anderson BO, et al. Global cancer surgery: delivering safe, affordable, and timely cancer surgery. Lancet Oncol. 2015;16:1193–224 Comprehensive look at the need for cancer surgery worldwide, presented by the Lancet Oncology Commission. Describes gaps in access to surgery, need for surgical personnel, and lack of key adjunct treatment modalities.CrossRefPubMed
32.
Shrime MG, Bickler SW, Alkire BC, Mock C. Global burden of surgical disease: an estimation from the provider perspective. Lancet Glob Health. 2015;3(Suppl 2):S8–9.CrossRefPubMed
33.
34.
• Pfister DG, Rubin DM, Elkin EB, Neill US, Duck E, Radzyner M, et al. Risk adjusting survival outcomes in hospitals that treat patients with cancer without information on cancer stage. JAMA Oncol. 2015;1:1303–10Large differences in cancer survival exist for patients over 65 between different classes of hospitals within the USA, even after risk adjustment.CrossRefPubMedPubMedCentral
35.
• Sirohi B, Chalkidou K, Pramesh CS, et al. Developing institutions for cancer care in low-income and middle-income countries: from cancer units to comprehensive cancer centres. Lancet Oncol. 2018;19:e395–406Overview of cancer center development history and the current development of cancer centers in low- and middle-income countries.CrossRefPubMed
36.
Monk TG, Saini V, Weldon BC, Sigl JC. Anesthetic management and one-year mortality after noncardiac surgery. Anesth Analg. 2005;100:4–10.CrossRefPubMed
37.
Lindholm M-LL, Träff S, Granath F, Greenwald SD, Ekbom A, Lennmarken C, et al. Mortality within 2 years after surgery in relation to low intraoperative bispectral index values and preexisting malignant disease. Anesth Analg. 2009;108:508–12.CrossRefPubMed
38.
•• Tohme S, Simmons RL, Tsung A. Surgery for cancer: a trigger for metastases. Cancer Res. 2017;77:1548–52 This review summarizes current research linking surgery, anesthesia, and inflammation to cancer recurrence.CrossRefPubMedPubMedCentral
39.
Horowitz M, Neeman E, Sharon E, Ben-Eliyahu S. Exploiting the critical perioperative period to improve long-term cancer outcomes. Nat Rev Clin Oncol. 2015;12:213–26.CrossRefPubMedPubMedCentral
40.
Musser JE, Assel MJ, Meeks JJ, Sjoberg DD, Vickers AJ, Coleman JA, et al. Ambulatory extended recovery: safely transitioning to overnight observation for minimally invasive prostatectomy. Urol Pract. 2015;2:121–5.CrossRef
41.
• Chiu C, Aleshi P, Esserman LJ, Inglis-Arkell C, Yap E, Whitlock EL, et al. Improved analgesia and reduced post-operative nausea and vomiting after implementation of an enhanced recovery after surgery (ERAS) pathway for total mastectomy. BMC Anesthesiol. 2018;18:41 Study comparing mastectomy outcomes before and after implementation of an Enhanced Recovery After Surgery (ERAS) pathway. The ERAS group had lower perioperative opioid consumption, lower incidence of postoperative nausea and vomiting, but no difference in length of stay.CrossRefPubMedPubMedCentral
42.
McEvoy MD, Wanderer JP, King AB, Geiger TM, Tiwari V, Terekhov M, Ehrenfeld JM, Furman WR, Lee LA, Sandberg WS. A perioperative consult service results in reduction in cost and length of stay for colorectal surgical patients: evidence from a healthcare redesign project. Perioper Med. 2016;1–10.
43.
Chapman JS, Roddy E, Ueda S, Brooks R, Chen L-L, Chen L-M. Enhanced recovery pathways for improving outcomes after minimally invasive gynecologic oncology surgery. Obstet Gynecol. 2016;128:138–44.CrossRefPubMed
44.
•• Aloia TA, Zimmitti G, Conrad C, Gottumukalla V, Kopetz S, Vauthey JN. Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy. J Surg Oncol. 2014;110:107–14 Patients who failed to return to intended oncologic therapy had lower disease-free and overall survival. All patients who had minimally invasive surgery completed the intended oncologic therapy, versus only 75% of patients who had surgery via open approach.CrossRefPubMedPubMedCentral
45.
Memeo R, de Blasi V, Adam R, et al. Postoperative infectious complications impact long-term survival in patients who underwent hepatectomies for colorectal liver metastases: a propensity score matching analysis. J Gastrointest Surg. 2018. https://​doi.​org/​10.​1007/​s11605-018-3854-2.
46.
Tevis SE, Kohlnhofer BM, Stringfield S, Foley EF, Harms BA, Heise CP, et al. Postoperative complications in patients with rectal cancer are associated with delays in chemotherapy that lead to worse disease-free and overall survival. Dis Colon Rectum. 2013;56:1339–48.CrossRefPubMed
47.
Luc G, Durand M, Chiche L, Collet D. Major post-operative complications predict long-term survival after esophagectomy in patients with adenocarcinoma of the esophagus. World J Surg. 2015;39:216–22.CrossRefPubMed
48.
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7–30 Annual statement of trends in US cancer mortality and incidence, focusing on regional and racial disparities.CrossRefPubMed
Metadaten
Titel
Cancer Tsunami: Emerging Trends, Economic Burden, and Perioperative Implications
verfasst von
Patrick J. McCormick
Publikationsdatum
01.12.2018
Verlag
Springer US
Erschienen in
Current Anesthesiology Reports / Ausgabe 4/2018
Elektronische ISSN: 2167-6275
DOI
https://doi.org/10.1007/s40140-018-0294-1

Weitere Artikel der Ausgabe 4/2018

Current Anesthesiology Reports 4/2018 Zur Ausgabe

Cancer Anesthesia (B Riedel and V Gottumukkala, Section Editors)

Organization of Multidisciplinary Cancer Care for the Surgical Patient: Role of Anesthesiologists

Cancer Anesthesia (B Riedel and V Gottumukkala, Section Editors)

Intensive Care Practice in the Cancer Patient Population: Special Considerations and Challenges

Cancer Anesthesia (B Riedel and V Gottumukkala, Section Editors)

Local Anesthetics (LAs) and Cancer Cell Progression: Is There an Oncologic Protective Role for LAs in Clinical Practice?

Cancer Anesthesia (B Riedel and V Gottumukkala, Section Editors)

Cancer Biology: a Primer for Perioperative Clinicians

Cancer Anesthesia (B Riedel and V Gottumukkala, Section Editors)

Propofol (TIVA) Versus Volatile-Based Anesthetics: Is There Any Oncological Benefit?

Cancer Anesthesia (B Riedel and V Gottumukkala, Section Editors)

Transfusion Therapy: Is There a Link with Cancer Recurrence?

Neu im Fachgebiet AINS

24.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Magen-Darm-Blutungen werden präklinisch oft falsch eingeschätzt

23.04.2024 | DGIM 2024 | Kongressbericht | Nachrichten

Sepsis-Verdacht: Eine Stunde, fünf essenzielle Maßnahmen

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Leitsymptom Rückenschmerzen | Nachrichten

Ärztliche Empathie hilft gegen Rückenschmerzen
weitere anzeigen

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren